Finland· FI-REL-REL3082

Furesis

A furosemide product containing furosemide, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 19 of our 19 countries.

ATC C03CA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedFuresisATCC03CA01REGISTER NO.FI-REL-REL3082PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Furosemide is registered in 19 of 19 countries.

Countries holding a registration under ATC C03CA01 (furosemide), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 11 of them publish a price we can compare per daily dose

Furosemide · ATC C03CA01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of furosemide costs, country by country.

Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.029 in United States to $0.25 in Switzerland — a ×8.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Furosemide · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.25
  • IT Italy$0.072
  • FR France$0.070
  • US United States$0.029 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Furosemide
Manufacturer
Orion Corporation Orion Pharma
Country
Finland (FI)
ATC code
C03CA01
ATC class
Furosemide
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

424 interactions on record for furosemide.

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Furosemide · interactions on record

424 records

  • 15 severe
  • 191 moderate
  • 13 minor
  • 203 info

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Furosemide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All furosemide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Furohexal, Furon
  • Belgium · Furosemide Eg, Lasix
  • Bulgaria · Furosemide Basi, Фурантрил
  • Cyprus · Furosemide Accord, Furosemide Waymade
  • Czechia · Furon, Furorese
  • Germany · Furanthril, Furo-Ct
  • Denmark · Diural, Furix
  • Estonia · Furosemide Accord, Furosemide Basi
  • Spain · Furosemida Altan, Furosemida Aurovitas
  • France · Furosemide Accord, Furosemide Arrow
  • United Kingdom (Northern Ireland) · Frusol, Furosemide
  • Greece · Demefur, Fudesix
  • Croatia · Edemid, Edemid Forte
  • Hungary · Furon, Furosemid Al
  • Ireland · Furosemide, Furosemide Accord Healthcare Ireland
  • Iceland · Furix, Furosemide Kalceks
  • Italy · Furosemide Aurobindo, Furosemide Aurobindo Italia
  • Lithuania · Furosemid Polpharma, Furosemide Accord
  • Luxembourg · Furosemid Ratiopharm, Furosemide Eg
  • Latvia · Furosemide Basi, Furosemide Kalceks
  • Malta · Furosemide Accord Healthcare, Furosemide Clonmel
  • Netherlands · Furosemide Accord, Furosemide Auro
  • Norway · Diural, Furix
  • Poland · Furosemid Accord, Furosemid Hameln
  • Portugal · Entix, Frunov
  • Romania · Furosemid Arena, Furosemid Basi
  • Sweden · Furix, Furosemid Accord
  • Slovenia · Edemid, Furosemid Hameln
  • Slovakia · Furon, Furorese

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/17960745-3ca7-42a7-aba4-98995096b73e
GET /v1/drugs/17960745-3ca7-42a7-aba4-98995096b73e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "40",
  "form": "depotkapseli, kova",
  "route": null,
  "ddd_unit": "mg",
  "strength": "60 mg",
  "atc_label": "furosemidi",
  "ma_number": "10628",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL3082",
  "authorised_at": "1992-01-15"
}

See everything about furosemide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.